Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon

NCT03563937 · clinicaltrials.gov ↗

COMPLETED

Status

64920

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Phenprocoumon
DRUG: Apixaban
DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Edoxaban

Sponsor

Bayer

Collaborators

[object Object]